Ledger.Open graph →
SEC Form D · filed September 27, 2017

LifeMine Therapeutics, Inc

Offering
$55.1M
Sold
$25.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Omar N. Blayton · CAMBRIDGE, MADirectorHelen Thornton · Hamilton, BermudaDirectorJonathan N. Abe · CAMBRIDGE, MAExec · DirectorTravis J. Putnam · Los Angeles, CAExecHingge L. Hsu · Cambridge, MAExecRichard L. Klausner · Cambridge, MADirectorRich Levandov · San Francisco, CAExecBrady Bohrmann · San Francisco, CAExec · DirectorKaiwalya Kher · San Francisco, CADirectorMichael Bach · San Francisco, CADirectorJim L. Tananbaum · Cambridge, MADirectorEdward L. Hu · Cambridge, MADirectorHingge L. Hsu · Cambridge, MAExecRichard L. Klausner · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗